Previous Issue
Volume 93, September
 
 

Sci. Pharm., Volume 93, Issue 4 (December 2025) – 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
17 pages, 4604 KB  
Article
Modulation of Antimicrobial Peptide–Membrane Interactions by Lysyl-Phosphatidylglycerol in Staphylococcus aureus: An FTIR Spectroscopy Study
by Andrea Vásquez, Sofía Echeverri-Gaviria and Marcela Manrique-Moreno
Sci. Pharm. 2025, 93(4), 49; https://doi.org/10.3390/scipharm93040049 - 15 Oct 2025
Abstract
Changes in membrane lipid composition constitute a key bacterial resistance mechanism. In Staphylococcus aureus, phosphatidylglycerol undergoes lysine modification to form lysyl-phosphatidylglycerol, a cationic lipid that reduces the net negative surface charge and thereby enhances resistance to cationic antimicrobial peptides. In this study, [...] Read more.
Changes in membrane lipid composition constitute a key bacterial resistance mechanism. In Staphylococcus aureus, phosphatidylglycerol undergoes lysine modification to form lysyl-phosphatidylglycerol, a cationic lipid that reduces the net negative surface charge and thereby enhances resistance to cationic antimicrobial peptides. In this study, we examined the influence of lysyl-PG on the membrane activity of three antimicrobial peptides with distinct physicochemical characteristics: LL-37, F5W Magainin II, and NA-CATH:ATRA-1-ATRA-1. Model membranes composed of phosphatidylglycerol and cardiolipin were supplemented with increasing molar fractions of lysyl-phosphatidylglycerol, and peptide–membrane interactions were characterized using Fourier-transform infrared spectroscopy. Membrane fluidity was evaluated through shifts in the symmetric methylene stretching bands, while changes in interfacial polarity were assessed via the carbonyl and phosphate asymmetric stretching bands. LL-37 induced pronounced disruption of anionic bilayers, an effect progressively attenuated by lysyl-phosphatidylglycerol, particularly within the hydrophobic core. F5W Magainin perturbed both hydrophobic and interfacial regions across a broader range of lysyl-phosphatidylglycerol concentrations, whereas NA-CATH:ATRA-1-ATRA-1 primarily targeted interfacial domains, with minimal disruption of acyl chain order. Increasing lysyl-PG content modulated the extent of bilayer disorder and dehydration at the hydrophobic–hydrophilic interface, with each peptide exhibiting a distinct interaction profile. Collectively, these findings provide mechanistic insights into lysyl-PG-mediated modulation of peptide activity and highlight the role of lipid remodeling as a bacterial defense strategy. Full article
Show Figures

Figure 1

20 pages, 2370 KB  
Article
Pumpkin Seeds Harbor Hidden Agonists: Adenosine-Mediated A1 Receptor Activation and Antioxidant Activity
by Adina-Elena Grasu, Roman Senn, Christiane Halbsguth, Alexander Schenk, Veronika Butterweck, Giulia Zecchin, Ionel I. Mangalagiu, Cătălina-Ionica Ciobanu and Anca Miron
Sci. Pharm. 2025, 93(4), 48; https://doi.org/10.3390/scipharm93040048 - 30 Sep 2025
Viewed by 258
Abstract
Hydroethanolic Cucurbita pepo seed extracts are traditionally used for alleviating lower urinary tract symptoms (LUTS), yet their mechanisms remain unclear. Adenosine, a purine nucleoside involved in neuromodulation and smooth muscle relaxation, was recently identified in C. pepo seeds. Since A1 adenosine receptors [...] Read more.
Hydroethanolic Cucurbita pepo seed extracts are traditionally used for alleviating lower urinary tract symptoms (LUTS), yet their mechanisms remain unclear. Adenosine, a purine nucleoside involved in neuromodulation and smooth muscle relaxation, was recently identified in C. pepo seeds. Since A1 adenosine receptors (A1AR) suppress parasympathetic bladder overactivity by inhibiting acetylcholine (ACh) release, we investigated to which extent purines from pumpkin seed extracts contribute to A1AR activation. Complementary antioxidant capacity was assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Three hydrophilic seed extracts containing different adenosine levels (0.60–1.18 mg/g dw) were evaluated for agonist activity using a cAMP inhibition assay. The most active extract showed an EC50 of 40.22 µg/mL. Selective removal of adenosine shifted the dose–response curve rightward, while further elimination of an adenosine derivative increased the EC50 to 212.10 µg/mL, confirming adenosine as the principal active compound. Guanosine and inosine did not exhibit A1AR agonist or allosteric effects. All samples exhibited measurable but weak antioxidant activity (IC50 = 1.02–4.19 mg/mL), consistent with their low total phenolic content. These findings underscore the importance of accounting for naturally occurring agonists in plant extracts to avoid overestimating receptor-mediated effects in vitro which are not translatable in vivo. Full article
Show Figures

Figure 1

29 pages, 1519 KB  
Review
Normalization of Immune Response via Chondroitin Sulfate and Fucoidan Targeting N-Acetylgalactosaminidase
by Jozef Zima, Eva Nováková, Miroslava Špaglová and Miroslava Šupolíková
Sci. Pharm. 2025, 93(4), 47; https://doi.org/10.3390/scipharm93040047 - 25 Sep 2025
Viewed by 537
Abstract
This review explores the pharmacological potential of chondroitin sulfate and fucoidan as immunomodulatory agents targeting N-acetylgalactosaminidase (nagalase) to normalize immune responses. Nagalase, an enzyme produced by tumor and virus-infected cells, contributes to immune suppression by deactivating macrophage-activating factor. Both chondroitin sulfate and fucoidan, [...] Read more.
This review explores the pharmacological potential of chondroitin sulfate and fucoidan as immunomodulatory agents targeting N-acetylgalactosaminidase (nagalase) to normalize immune responses. Nagalase, an enzyme produced by tumor and virus-infected cells, contributes to immune suppression by deactivating macrophage-activating factor. Both chondroitin sulfate and fucoidan, as representatives of glycosaminoglycans and heteropolysaccharides, exhibit significant potential in inhibiting nagalase activity, thereby restoring immune functionality. Chondroitin sulfate, a key component of the extracellular matrix, demonstrates anti-inflammatory and tissue-regenerative properties by modulating nuclear factor (NF)-κB pathways and cytokine expression. Fucoidan, a sulfated polysaccharide derived from brown seaweed, enhances immune responses through macrophage and natural killer cell activation, while also exhibiting antiviral and anticancer activities. This dual action positions these compounds as promising agents for therapeutic interventions in chronic inflammatory conditions, cancer, and infectious diseases. The synergistic effects of chondroitin sulfate and fucoidan highlight their potential to address the root causes of immune dysregulation. This review aims to elucidate the underlying mechanisms of action and explore the clinical applications of these compounds within the framework of innovative immunotherapeutic strategies. However, current evidence is limited by the predominance of preclinical studies and variability in experimental models. Well-designed clinical trials are needed to validate their efficacy for therapeutic use. Full article
Show Figures

Figure 1

Previous Issue
Back to TopTop